Search

everythinglearnresearchcommunity

for

Search:↓

Machine learning identified three unique subtypes of androgen excess in women with PCOS, each with different metabolic risks.

The mTurq2-Col4a1 mouse model shows that cells can divide while attached to stable basement membranes during development.

Baricitinib is a promising treatment for alopecia areata.

Baricitinib effectively regrows hair in most people with severe alopecia, especially those with patchy hair loss, but hair may fall out again if treatment stops.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

Bacterial communities on scalp hair are unique to each person but consistent across different scalp sites.

Bariatric surgery improved many skin conditions in obese patients but caused hair loss in some and decreased facial oil and skin elasticity.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.

Baricitinib shows promise in treating severe hair loss.

Baricitinib treatment can help regrow scalp hair and eyebrows or eyelashes in people with severe alopecia areata.

The document's conclusion cannot be provided because the content is not available.

A man developed oral hairy leukoplakia while on baricitinib, a medication for alopecia and arthritis, and doctors should watch for such side effects.

There are effective treatments available for baldness.

A new wound healing treatment using a graphene-based material with white light speeds up healing and reduces infection and scarring.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Combining baricitinib with low-dose corticosteroids significantly improved severe hair loss in eight patients.

DFMO treatment improves hair growth, muscle tone, and development in Bachmann-Bupp syndrome patients.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.

Botulinum toxin type A helps treat hair loss by stopping cell death in hair follicles through a process involving certain non-coding RNAs and a protein called Bax.

Neurosteroids help regulate oxytocin levels, especially during stress and pregnancy, to protect against premature labor.

Using platelet-rich plasma, basic fibroblast growth factor, and minoxidil together significantly increases hair count and growth rate in people with hair loss.

Enzymatic synthesis improved the water solubility of the flavonoid baicalin, which may help treat hair loss conditions.

Baricitinib is a promising treatment for severe alopecia areata with minimal side effects.

Baricitinib at 2mg and 4mg doses improved work productivity and reduced costs for adults with atopic dermatitis.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

Baricitinib is effective in promoting hair growth in severe alopecia areata.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.